Mefeserpine

This classification denotes an antihypertensive agent with the molecular formula C32H38N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42EL4L295A, chemically known as 3beta,20alpha-yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, (p-methoxyphenoxy)acetate (ester) but generally known as mefeserpine, which bears US NIH Compound Identifier 3045407. European Medicines Agency schedules Mefeserpine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08707MIG. The term MEFESERPINE is an International Non-Proprietary Name. MEFESERPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mefeserpine under HS 29399900 and SITC 54149. As of Q4 2014, MEFESERPINE remains the US FDA Preferred Term for this commodity. Mefeserpine bears US NLM identifiers UMLS ID C2981312 and NCI Concept Code C87628. SMILES: O(C1C(C2C(CN3C(C2)c2[nH]c4c(c2CC3)ccc(OC)c4)CC1OC(=O)COc1ccc(OC)cc1)C(=O)OC)C.